234 related articles for article (PubMed ID: 7650478)
1. Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion.
Zhang X; Giangreco L; Broome HE; Dargan CM; Swain SL
J Exp Med; 1995 Sep; 182(3):699-709. PubMed ID: 7650478
[TBL] [Abstract][Full Text] [Related]
2. Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages.
Duncan DD; Swain SL
Eur J Immunol; 1994 Oct; 24(10):2506-14. PubMed ID: 7925578
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF.
Joseph SB; Miner KT; Croft M
Eur J Immunol; 1998 Jan; 28(1):277-89. PubMed ID: 9485207
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.
Tiemessen MM; Kunzmann S; Schmidt-Weber CB; Garssen J; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
Int Immunol; 2003 Dec; 15(12):1495-504. PubMed ID: 14645158
[TBL] [Abstract][Full Text] [Related]
5. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
Croft M; Swain SL
J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta 1 induces antigen-specific unresponsiveness in naive T cells.
Gilbert KM; Thoman M; Bauche K; Pham T; Weigle WO
Immunol Invest; 1997 Jun; 26(4):459-72. PubMed ID: 9246566
[TBL] [Abstract][Full Text] [Related]
7. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.
Croft M; Carter L; Swain SL; Dutton RW
J Exp Med; 1994 Nov; 180(5):1715-28. PubMed ID: 7525836
[TBL] [Abstract][Full Text] [Related]
8. Deletion, but not anergy, is involved in TGF-beta-treated antigen-presenting cell-induced tolerance.
Alard P; Clark SL; Kosiewicz MM
Int Immunol; 2003 Aug; 15(8):945-53. PubMed ID: 12882832
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype.
Swain SL; Huston G; Tonkonogy S; Weinberg A
J Immunol; 1991 Nov; 147(9):2991-3000. PubMed ID: 1680924
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-modulated regulation of helper T cell populations.
Yates A; Bergmann C; Van Hemmen JL; Stark J; Callard R
J Theor Biol; 2000 Oct; 206(4):539-60. PubMed ID: 11013114
[TBL] [Abstract][Full Text] [Related]
11. The effect of TGF-beta1 on immune responses of naïve versus memory CD4+ Th1/Th2 T cells.
Lúdvíksson BR; Seegers D; Resnick AS; Strober W
Eur J Immunol; 2000 Jul; 30(7):2101-11. PubMed ID: 10940900
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
[TBL] [Abstract][Full Text] [Related]
13. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation.
Takeuchi M; Kosiewicz MM; Alard P; Streilein JW
Eur J Immunol; 1997 Jul; 27(7):1648-56. PubMed ID: 9247573
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression.
Weller M; Constam DB; Malipiero U; Fontana A
Eur J Immunol; 1994 Jun; 24(6):1293-300. PubMed ID: 8206089
[TBL] [Abstract][Full Text] [Related]
15. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
Lee HM; Rich S
J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice.
Maeda H; Shiraishi A
J Immunol; 1996 Jan; 156(1):73-8. PubMed ID: 8598496
[TBL] [Abstract][Full Text] [Related]
17. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
Niedbala W; Wei X; Liew FY
Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
[TBL] [Abstract][Full Text] [Related]
18. Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo.
Bradley LM; Harbertson J; Biederman E; Zhang Y; Bradley SM; Linton PJ
Eur J Immunol; 2002 Aug; 32(8):2338-46. PubMed ID: 12209647
[TBL] [Abstract][Full Text] [Related]
19. IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12.
Lingnau K; Hoehn P; Kerdine S; Koelsch S; Neudoerfl C; Palm N; Ruede E; Schmitt E
J Immunol; 1998 Nov; 161(9):4709-18. PubMed ID: 9794401
[TBL] [Abstract][Full Text] [Related]
20. B cell response to T helper cell subsets. II. Both the stage of T cell differentiation and the cytokines secreted determine the extent and nature of helper activity.
Croft M; Swain SL
J Immunol; 1991 Dec; 147(11):3679-89. PubMed ID: 1682380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
